Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

What You Need to Know Ahead of AbbVie’s Earnings Release

With a market cap of $384.6 billion, AbbVie Inc. (ABBV) is a global research-driven pharmaceutical company that develops and markets advanced therapies across immunology, oncology, neuroscience, and aesthetics. The Illinois-based company is known for blockbuster drugs like Humira and newer growth drivers such as Skyrizi and Rinvoq. 

The drug giant is expected to announce its fiscal first-quarter earnings for 2026 on Friday, Apr. 24, before the market opens. Ahead of the event, analysts expect ABBV to report a profit of $3.01 per share on a diluted basis, up 22.4% from $2.46 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.